| scholarly article | Q13442814 |
| P50 | author | Satoru Yamaguchi | Q79414705 |
| P2093 | author name string | Kazuyuki Kojima | |
| Kinro Sasaki | |||
| Masanobu Nakajima | |||
| Takashi Tsuchioka | |||
| Yosuke Shida | |||
| Keisuke Ihara | |||
| Hiroto Muroi | |||
| Maiko Kikuchi | |||
| Junki Fujita | |||
| Shotaro Matsudera | |||
| P2860 | cites work | Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans. | Q30625567 |
| Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. | Q33839100 | ||
| Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial | Q34607843 | ||
| Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas | Q43724018 | ||
| Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma | Q43875251 | ||
| Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment | Q44820379 | ||
| Assessing the initiation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stage-III colon cancer | Q45256282 | ||
| Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients | Q58614888 | ||
| [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients] | Q70507813 | ||
| Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma | Q74416456 | ||
| Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer | Q79634887 | ||
| Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer Abstracted from: Andre T, Boni C, Mounedji-Boudiaf L, | Q80996942 | ||
| The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma | Q82794556 | ||
| Evaluation of the seventh edition of the tumour, node, metastasis (TNM) classification for colon cancer in two nationwide registries of the United States and Japan | Q82998331 | ||
| Duration of adjuvant chemotherapy for colon cancer and survival among the elderly | Q83162125 | ||
| Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer | Q84570414 | ||
| Nutritional predictors of postoperative outcome in pancreatic cancer | Q85226329 | ||
| The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage | Q86282781 | ||
| Low nutritional prognostic index correlates with poor survival in patients with stage IV colorectal cancer following palliative resection of the primary tumor | Q86891421 | ||
| P433 | issue | 2 | |
| P921 | main subject | colorectal cancer | Q188874 |
| P304 | page(s) | 78-83 | |
| P577 | publication date | 2019-04-25 | |
| P1476 | title | Nutritional status predicts adjuvant chemotherapy outcomes for stage III colorectal cancer | |
| P478 | volume | 3 |
Search more.